Companies /Consumer Cyclical

Starbucks Corp

NASDAQ: SBUX Restaurants
$108.30
â–² $1.04 (+0.97%) today
Markets open · 3:26pm ET

Q3 2025 Earnings

Reported Jul 29, 2025, 4:06pm ET · SEC source
$0.50
Miss −22.56%
EPS · est. $0.65
$9.5B
Beat +1.58%
Revenue · est. $9.3B
−7.5%
Trailing market
SBUX vs S&P since report
2 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−3%0+3%+6%Jul 29Jul 30report 4:06pm ETearnings+0.6%−0.4%
−3%0+3%+6%Jul 29Jul 30earnings+0.6%−0.4%
SBUX −0.4%S&P 500 +0.6%
−3%0+3%+6%Jul 29Jul 30report 4:06pm ETearnings+1.2%−0.4%
−3%0+3%+6%Jul 29Jul 30earnings+1.2%−0.4%
SBUX −0.4%NASDAQ +1.2%
−8%−4%0Jul 28Aug 6report 4:06pm ETearnings−0.4%−6.9%
−8%−4%0Jul 28Aug 6earnings−0.4%−6.9%
SBUX −6.9%S&P 500 −0.4%
−8%−4%0Jul 28Aug 6report 4:06pm ETearnings+0.1%−6.9%
−8%−4%0Jul 28Aug 6earnings+0.1%−6.9%
SBUX −6.9%NASDAQ +0.1%
−0.76%
Day of report
−0.22%
Next session
−2.97%
One week
−5.31%
30 days

S&P 500 over the same 30 days: +2.15%.

Did SBUX Beat Earnings? Q3 2025 Results

Starbucks delivered a split verdict in its fiscal third quarter of 2025, posting revenue that edged past Wall Street's expectations while earnings fell well short, underscoring how much heavy lifting the company's turnaround still requires. Revenue rose 3.8% year-over-year to $9.46 billion, clearing the $9.31 billion consensus by 1.58%, but non-GAAP EPS of $0.50 missed the $0.65 estimate by 22.56%, tumbling 46% from the prior-year period. The sharpest culprit was a combination of one-time investments, including a three-day Leadership Experience conference for more than 14,000 coffeehouse managers, and a discrete tax item that together shaved roughly $0.11 from earnings, pushing the effective tax rate to 31.8% from 24.8% a year ago. Global comparable store sales declined 2%, with North America comps falling the same amount, though China offered a relative bright spot with a 2% comp gain. CEO Brian Niccol declared the turnaround is "ahead of schedule" and promised a wave of product innovation in fiscal 2026, a pledge that analysts are watching closely given the ongoing tension between ambitious reinvention and the need for faster, more consistent service.

Key Takeaways
  • Net new company-operated store growth of 5% in North America and 7% internationally over the past 12 months
  • Global comparable store sales declined 2%, driven by 2% decline in comparable transactions partially offset by 1% increase in average ticket
  • China comparable store sales increased 2% driven by 6% increase in comparable transactions
  • Channel Development revenue increased 10% driven by Global Coffee Alliance growth
  • Operating margin contracted 680 bps due to deleverage, labor investments, Leadership Experience 2025, and inflation
  • Effective tax rate increased to 31.8% from 24.8% driven by discrete impact of changes in indefinite reinvestment assertions (~850 bps impact)
  • Three consecutive quarters of improving U.S. transaction comp

“We've fixed a lot and done the hard work on the hard things to build a strong operating foundation, and based on my experience of turnarounds, we are ahead of schedule.”

Starbucks CEO, on the earnings call

Forward Guidance & Outlook

CEO Brian Niccol stated the company is 'ahead of schedule' on its turnaround and plans to 'unleash a wave of innovation' in fiscal 2026 to fuel growth and elevate customer service. CFO Cathy Smith emphasized the company is focused on 'growing back better and delivering durable, sustainable long-term growth.' The company did not provide specific quantitative financial guidance for future periods.

SBUX YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$3.0B$6.0B$9.0B$9.1B$9.5BRevenue$1.5B$935.6MOperating Income$1.1B$558.3MNet Income
$0$3.0B$6.0B$9.0BRevenueOperating IncomeNet Income

SBUX Revenue by Segment

Company-Operated Stores$7.8B+3.9%
Licensed Stores$1.1B−2.1%
Channel Development$483.8M+10.0%

SBUX Revenue by Geography

North America
United States$6.5B+1.0%
International
China$790.0M+8.0%

Figures from SEC filings and company reports. Not investment advice.